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Autism Spectrum Disorder (ASD) is a “spectrum” of disorders, characterized by varying degrees of symptoms ranging from mild 
to severe. Among Psychiatric disorders, Autism Spectrum Disorders have the strongest evidence for a genetic basis, yet the search 
for specific genes contributing to these often devastating developmental syndromes has proven extraordinarily difficult.  Bipolar 
Disorder (BP) is a manic-depressive disorder whose symptoms are characterized by extremities in moods. It is also called as the 
“Mood disorder”. BP, like, ASD also has a strong genetic basis and identification of the candidate genes still remains an ongoing 
effort. Literature studies point to the hypothesis that ASD and BP have good chances of comorbidity and that they may share 
common pathways for their manifestation. But this hypothesis has not been worked on in depth. Thus, the study focuses on 
identifying the chances of their comorbidity by identifying their common pathways and the genes involved in the pathways and 
also discuss the degree of chances of their comorbidity based on the genes involved in the common pathways. Networks for the 
genes are also constructed to represent their commonness or uniqueness for the disorders. 
 
 






Systems Biology involves the study of the interactions of 
biological systems and ultimately their functions. 
Understanding the structure of the system, such as gene 
regulatory and biochemical networks, dynamics of the system 
involving both quantitative and qualitative analysis and 
construction of theory/model with powerful prediction 
capability, control methods of the system and design methods 
of the system are the key milestones to the Systems Biological 
study [1]. Autism Spectrum Disorders (ASDs) are a group of 
related neuro-developmental disorders characterized by 
delayed or abnormal language development, deficits in social 
interaction and restricted, repetitive behaviors and interests 
(Valerie W.Hu. 2009) [2]. They are pervasive developmental 
disorders that include Autistic disorder, Asperger syndrome, 
Pervasive Developmental Disorder- Not Otherwise Specified 
(PDD-NOS) and the rare disorders that include Rett disorder 
and Childhood Disintegrative Disorder (CDD). These 
conditions are complex, behaviorally-defined syndromes with 
variable, severity and highly diverse symptoms and etiologies 
[3]. The most recent survey data estimates that, more than 1 in 
150 children in the US may have an ASD diagnosis. Most 
estimates are based on population and there has been little 
evidence of variation based on geographic region. This makes 
ASDs the third most common developmental disorders [4].  
 
Bipolar disorder (BP) is another common psychiatric disorder 
categorized under the Mood Disorders. It is characterized by 
mood alterations, with recurrent depressive and manic episodes 
in lifetime. Extreme changes in energy, activity, sleep, and 
behavior go along with these changes in mood. An overly joyful 
or overexcited state is called a manic episode, and an extremely 
sad or hopeless state is called a depressive episode. Manic 
episode is characterized by elated mood, grandiosity, pressure BIOINFORMATION  open access 
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to kee p talking,  flight of id eas, hyp era ctivi ty and  dim inished 
need for sleep. Depressive episode is characterized by 
depressed mood, loss of interest, appetite loss, sleep 
disturbance, psychomotor retardation, feelings of worthlessness 
and suicidal ideation [5]. Zutshi A et al. (2011) [6] has indicated 
that diagnosis of BP changed from 2.5% in 2004 to 3.3% in 2008. 
There was a significant increase in the prevalence of BP in 2008. 
Carroll and Owen (2009) [7] showed with evidences that ASDs, 
schizophrenia and BP have a convergence on the specific 
processes involved in the development and regulation of 
synaptic transmission. It has been hypothesized that the neural 
systems responsible for the regulation of circadian rhythm, 
synthesis of neurotransmitters such as dopamine and GABA 
can play a significant role in the etiology of disorders. Also, 
Rudan Igor (2010)  [8] has indicated that although psychiatric 
disorders are highly heritable, identifying their genetic basis has 
so far been challenging, with most discoveries failing to be 
replicated. A few studies have elucidated the comorbidity of the 
two psychiatric disorders and their relation, but a clear insight 
into the concept has not been established as yet.   
 
DeLong R (1994) [9] suggested that the pattern of affective and 
cognitive symptoms showed notable similarities across an 
entire group with ASD, with a family history of BPAD or major 
depression. Munesue T et al. (2008) [10] has emphasized BP as a 
comorbidity in high functioning ASD. He also speculated that 
the major comorbid mood disorder in patients with high 
functioning ASD is BP and also referred that both may share 
certain common vulnerability genes. Depression is the main 
psychiatric co-morbidity reported in individuals with ASD. It is 
considerably clear that lacunae pertaining to the comorbidity of 
ASD and BP exist at the genomic level. Thus, we have made an 
attempt to discover, understand, and interpret the relevance of 
comorbidity of the two disorders, carrying out in silico studies 
at the genomic level, contributing to the research that has 
progressed rapidly over the past few years due to the 
advancement of Bioinformatics applications. 
 
Methodology: 
Dataset Collection:   
A rigorous search for genes associated with autism spectrum 
disorders and bipolar disorder performed manually from 8 
sources viz., PubMed, Reactome [11], Genetic Association 
database [12], Huge Navigator [13], ENSEMBL [14], Cytoscape 
[15] and Sequence Retrieval System [16]. Around 714 genes and 
675 genes were collected for BP and ASD respectively. The 
collected genes were then validated using the databases- 
GENECARDS [17] and UNIPROTkb. 
 
Analysis:  
A bottom-up approach (exploring the pathways involved in the 
disorders from the list of genes that were collected, rather than 
the usual pathways to gene approach) was employed to build the 
further methodology of the experiment.  GeneGO Pathway 
maps (METACORE, GeneGo, Inc.) and CONSENSUSPATH 
database [18] was used for identifying the pathways to which 
the genes were associated. MetaCore (Thomson Reuter Inc) 
provides highly extensive grounds for analyzing pathways, 
building networks, analyzing expression profiles and many 
more. GeneGo Pathway Maps facility was chosen since it 
supports extensive analysis of pathways for gene lists imported 
by the user with an additional facility of Enrichment analysis. 
Pathways were ranked based on the P-Values and the enriched 
pathways were then listed with their Log P Values. Such 
efficient and extensive pathway analysis feature is considered 
the crux of the study. Consensuspath Database [18] offers an 
extensive integration of pathways from various manually 
curated pathway databases. Therefore, it could be considered to 
be a central hub of pathways. With regard to the study taken 
up, this database was observed to be very useful and efficient. 
Thus, it was chosen for the study. NAViGaTor [19] provides an 
efficient representation of the networks. It was chosen as the 
visualization tool for the study to depict the common and 
unique genes involved in the chosen pathways. The gene lists 
were submitted to the two tools individually and their 
corresponding pathways were recorded. An enrichment 
analysis was performed by the two tools and statistically 
significant pathways were noted. The common pathways 
involved in both the disorders, as recorded by the two tools 
w e r e  i n d i v id u a ll y  s h o rt l is t e d .  A s m a n y  a s  3 3  p a t h w a ys  w e r e  
recorded from metacore and 60 pathways from consensuspath 
database. A manual comparative study of the common 
pathways listed by both the tools was carried out and they were 
consolidated using knowledge from literature. Four pathways 
were identified to be common to both the disorders and are 
strongly associated with the basic etiology of the disorders.   
 
 
Figure 1: Networks for the chosen 4 pathways showing genes 
which are associated with ASDs or BP or common for both. (A) 
Network for Neuroactive Ligand Receptor Interaction Pathway 




The genes involved in these four pathways were then identified 
and a network for each of the 4 pathways was constructed 
using the tool NAViGaTOR [19] (Figure 2). Finally, the common 
genes associated with the two disorders were keyed out. BIOINFORMATION  open access 
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Figure 2: Methodology employed is depicted. 
 
Results: 
The initial data collection yielded around 675 genes for Autism 
Spectrum Disorder and 713 genes for Bipolar Disorder. The 
pathways associated with the genes have been recorded from 
both the consensuspath database and Metacore. A brief study 
on the pathways revealed that they are being regulated by 4 
primary pathways and those pathways are indispensable for 
the other pathways to function properly. They are: Neroactive 
Ligand Receptor Interaction Pathway (Figure 1A); Circadian 
Rhythm Pathway (Figure 1B); Synaptic Transmission (Figure 
1C);  Catecholamine Biosynthesis (Figure 1D); Thus, those 4 




Autism Spectrum Disorders and Bipolar disorder continue to 
prove a great challenge to the medical community due to their 
heterogeneity and gaps, in diagnosis. The chances of co-
morbidity of the disorders are also considerably strong with 
validated literature support [9, 10, 20]. ASDs and BP have also 
been shown to implicate a few common symptoms viz., sleep 
deprivation, depression, anxiety and social-behavioral 
problems. This similarity between the 2 disorders could be due 
to disturbances in their common pathways that may involve 
commonalities and uniqueness in the contributing genes. 
Taking into account the gaps in diagnosing the disorders and 
perplexities in identifying the chances of their co-morbidity and 
unclear and polygenic factors, they have been chosen as case 
studies for the work. Out of the 50-60 common pathways (as on 
April 28, 2011) that were recorded from the 2 methods, 4 major 
pathways were chosen since they were found to mediate the 
other pathways. Moreover, 70% of those pathways were 
observed to be derived from any one of the above mentioned 
four pathways namely, Neuroactive Ligand receptor interaction 
pathway, Circadian rhythm pathway, Synaptic transmission 
and Catecholamine biosynthesis.  
 
The Synaptic transmission pathway was observed to be 
extremely significant as it is the pathway through which the 
neurotransmitters- dopamine, serotonin, acetylcholine, Gamma 
Amino Butyric Acid, Glutamate, Substance P are synthesized 
and released to perform the highly important function of 
transmitting signals from a neuron to the target cells. Thus, any 
disturbances in the pathway can lead to a constellation of 
complexities in the system. The Neuroactive Ligand receptor 
interaction pathway was ranked as the pathway with the 
highest score (involving the greatest number of genes 
implicated in the two disorders) for both ASD and BP by the 
ConsensusPath database. The pathway utilizes the 
neurotransmitters glutamate, dopamine, serotonin, nor-
adrenaline as its starters and regulates certain crucial pathways 
that maintain mood and regulate stress such as, Long-term 
potentiation, Long-term depression, GnRH (Gonadotrophin 
Releasing Hormone) signaling and synthesis of Gap junction. 
The Circadian Rhythm pathway, is a key pathway to maintain 
the biological clock in our body and the CLOCK genes holds 
strong implications to be a factor for the disorders [21, 22]. 
Catecholamines are the “flight-fight” hormones that are 
released in response to stress. They include dopamine, 
epinephrine, and nor-epinephrine. The end product of this 
pathway nor-epinephrine mediates the synthesis of the 
corticosteroid- Cortisol by activating the Corticotropin-
Releasing hormone (CRH) along-with Adrenocorticotropic 
hormone (ACTH) in the pituitary gland. Cortisol is very 
important to regulate and handle stress and has innumerable 
functions in the body including mediating other hormones such 
as insulin, thyroxine, etc.  
 
In addition, cortisol content in the plasma might also play a 
pivotal role by influencing the production of Serotonin, which 
is the precursor for Melatonin, a hormone synthesized in the 
pineal gland. Both serotonin and melatonin are very significant 
to maintain an individual's appetite, muscle movements, bone 
formation, memory, circadian rhythm cycle and many other 
activities. Cortisol content is observed to increase up to 2-3 folds 
in the morning and decrease gradually with the day's progress. 
During the night hours, cortisol content drops down and the 
synthesis of serotonin and melatonin takes place. This process is 
a routine in our body and only when it occurs normally, our 
body can maintain its balance and handle stresses throughout 
the day. Elevated cortisol level hinders the synthesis of 
serotonin and thus decreases the serotonin and melatonin 
levels. This undesirable process can lead to implications such as 
stresses, depressions, abnormal mental states which are the 
symptoms of ASD and BP. Based on a careful study of the four 
pathways and subsequent examination of the other pathways 
involved in the list, the above mentioned 4 pathways were 
selected for further analysis. The chances of comorbidity of ASD 
and BP can be speculated by the genes involved in the 
pathways. Although, the 4 pathways were observed to be 
associated with both the disorders, the fate of the disorders can 
be determined by the genes that get involved. While 
scrutinizing the list of genes involved in each pathway that are 
implicated as candidates for both the disorders separately, 
certain common and unique features were observed. As 
represented by the 4 networks, both disorders have their own 
unique genes and share common genes too. This can lead us to 
the speculation that when a disruption occurs in the genes 
common to both the disorders in a pathway, the chances of co-
morbidity of ASD and BP can be considerably high. However, 
when there is a mutation in the genes associated with only one BIOINFORMATION  open access 
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disorder, the susceptibility rate of a person with any of the 
ASDs to BP can be considerably low. Thus, though certain 
pathways have been observed to be similar to both ASD and 
BP, the chances of their co-occurrence in an individual can 
depend on the nature of the genes which get disrupted. The 
results obtained indicate that, any disturbance in the Circadian 
rhythm pathway (Figure 1C), the chances of comorbidity of BP 
and ASD in a person can be higher as ASD shares all its genes 
with BP (Table 1, see Supplementary material). But, a person 
can be diagnosed with BP only, in his later life if there is any 
disruption in the genes unique to BP in the pathway. However, 
disturbances in the Neuroactive Ligand Receptor Interaction, 
Synaptic Transmission and Catecholamine Biosynthesis 
pathways (Figure 1A, 1B & 1D) could increase susceptibility to 
any of the ASDs, if the genes identified as unique for ASD are 
disrupted, or might be affected by BP alone, if the genes 
identified as unique for BP are disrupted. However, 
commonalities among the genes of the 2 disorders raise a 
speculation that the chances of co-morbidity of ASD and BP can 
be higher if disruptions occur in those genes.  
 
Conclusion:  
A systems biology study of Autism Spectrum Disorders (ASD) 
and Bipolar Disorder (BP) proved to yield important insight on 
the genetic basis of comorbidity between the two disorders.     
The networks constructed for the selected 4 pathways leads to a 
hypothesis that the comorbidity of ASD and BP can be 
correlated to the genes involved in the pathways common to 
the two disorders and a further examination can pave way to 
the identification of the specific genes that contribute to 
comorbidity. Such knowledge would help in devising a novel 
management technique or developing therapeutics.     
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Table 1: List of Genes Associated With Both ASD & BP Involved In the Selected Pathways 
Pathway  Genes common for ASD and BP 
Neuroactive Ligand 
Receptor Pathway 
AVPR1A, HTR1E, HTR1D, HTR1B, HTR1A, CNR1, HTR7, VIPR1, ADRA2A, LHCGR, GABRB3, GABRB1, 
OPRK1, GRIN2A, ADRA1B, GABRA6, GABRA5, GABRA4, GABRA3, ADRB2, GABRA2, GRIA3, 
GABRA1, PRLR, GRM8, GRM7,  ADORA2A, OXTR, DRD5, DRD4, DRD3, DRD2, DRD1,GRIK3, GRIK2, 
MCHR1, PRL, CRHR1, LEP, NPY5R, CHRM5, CHRM4, LEPR, CHRNA4, OPRD1, HTR5A, GABRG3, 
GABRG1, NPY2R, HTR2C, HTR2A, GRID2, GRID1, OPRM1, HCRTR2, HCRTR1 
Synaptic 
Transmission 
SLC1A1, SNAP25, GRIK3, GRIK2, GABRB3, GABRB1, GABRA6, GABRA5, GABRA4, GRIP1, GABRA3, 
GABRA2, GABRA1, GABRG3, COMT, DDC, GAD2, GAD1, DLG1, GRIA3, GRIN2A, MAOA, CHRNA4, 
SLC6A3, SLC6A1, TH, SLC1A3, SLC1A2 
Circadian Rhythm 
Pathway 
CLOCK, NPAS2, PER1, PER2, KC1E, BHE41 
Catecholamine 
Biosynthesis 
DDC, TY3H, DOPO 
 